Nordic private equity firm Summa Equity AB is exploring a sale of Finland’s HyTest Ltd., a manufacturer of antibodies and antigens used in tests for illnesses including Covid-19, people with knowledge of the matter said.
To read the entire story, you must be logged in.
Please log in now or register with us.
